Drug
ST 1481 clinical trials
Also written Gimatecan, ST1481 and LBQ707.
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 2
Lee's Pharmaceutical Limited (4) · Novartis Pharmaceuticals (3) · Sigma-Tau Research, Inc. (2) · M.D. Anderson Cancer Center (1) · Jonsson Comprehensive Cancer Center (1) · Novartis (1)
Studies
Open first, then newest update. How each study uses ST 1481 is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal CancerStatus unknownPhase 2Lee's Pharmaceutical LimitedNCT04846842Written as Gimatecan
- A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.CompletedPhase 1Novartis PharmaceuticalsNCT00410358Written as Gimatecan
- An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid TumorCompletedPhase 1Novartis PharmaceuticalsNCT00441610Written as Gimatecan
- A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic CancerStatus unknownPhase 2Lee's Pharmaceutical LimitedNCT04571489Written as Gimatecan
- A Study of Gimatecan (ST1481) in Small Cell Lung CancerStatus unknownPhase 2Lee's Pharmaceutical LimitedNCT04501029Written as Gimatecan
- A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerStatus unknownPhase 1Lee's Pharmaceutical LimitedNCT04029909Written as Gimatecan 0.6mg/m2/d
- Phase I Study of Gimatecan in Patients With Myelodysplastic SyndromesCompletedPhase 1M.D. Anderson Cancer CenterNCT00493571Written as Gimatecan
- Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaCompletedPhase 1/2Jonsson Comprehensive Cancer CenterNCT00087061Written as gimatecan
- Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid TumorsCompletedPhase 1Novartis PharmaceuticalsNCT00420485Written as gimatecan
- A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid TumorsCompletedPhase 1NovartisNCT00487058Written as Gimatecan
- This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.CompletedPhase 1/2Sigma-Tau Research, Inc.NCT00032903Written as Gimatecan® (ST 1481)
- This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid TumorCompletedPhase 1Sigma-Tau Research, Inc.NCT00033202Written as Gimatecan® (ST-1481)